Clinical Trials Directory

Trials / Completed

CompletedNCT03209427

Serum Serotonin and Pruritus After Intrathecal Morphine in Cesarean Section

Pruritus After Intrathecal Morphine in Cesarean Section: Incidence, Severity and Its Relation to Serum Serotonin Level

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Assiut University · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

Pruritus is the commonest side effect of intrathecal morphine especially in parturient, but the exact mechanism of pruritus is not clear. Many mechanisms have been suggested. Among these mechanisms is the activation of the 5-HT3 receptors by the intrathecally injected morphine.

Detailed description

Forty parturients underwent elective cesarean section under spinal anesthesia were divided into two groups of 20 each in this prospective randomized study. Group I received 100 µg of intrathecal morphine (ITM) mixed with 12 mg of 0.5% heavy bupivacaine (M100) while group II received 200 µg of ITM mixed with 12 mg of 0.5% heavy bupivacaine (M200). Two blood samples were taken from each patient for serotonin estimation, preoperatively and 4 hrs later. Postoperatively all patients were assessed for pruritus (incidence \& severity), visual analog scale (VAS), first request of analgesia, and total analgesic dose required within 24 hrs.

Conditions

Interventions

TypeNameDescription
DRUGMorphine 100 μgIntrathecal injection of morphine100 μg
DRUGMorphine 200 μgIntrathecal injection of morphine 200 μg

Timeline

Start date
2014-04-02
Primary completion
2015-04-30
Completion
2016-09-21
First posted
2017-07-06
Last updated
2017-07-06

Source: ClinicalTrials.gov record NCT03209427. Inclusion in this directory is not an endorsement.